Splicing programs and cancer

Journal of Nucleic Acids

Volumn 2012, Issue , 2012, Pages

  Germann, Sophie ^a,b,c   Gratadou, Lise ^a,b,c   Dutertre, Martin ^a,b,c   Auboeuf, Didier ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE RNA SPLICING; BIOTECHNOLOGY; CANCER GENETICS; CANCER GROWTH; CARCINOGENESIS; CELL FUNCTION; DRUG DEVELOPMENT; DRUG TARGETING; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 84868236149     PISSN: 20900201     EISSN: 2090021X     Source Type: Journal    
DOI: 10.1155/2012/269570     Document Type: Review

References (99)

1. Hallegger M., Llorian M., Smith C. W. J., Alternative splicing: global insights: minireview. FEBS Journal 2010 277 4 856 866 2-s2.0-76149130971 10.1111/j.1742-4658.2009.07521.x
2. Pan Q., Shai O., Lee L. J., Frey B. J., Blencowe B. J., Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature Genetics 2008 40 12 1413 1415 2-s2.0-56749098074 10.1038/ng.259
3. Wang E. T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S. F., Schroth G. P., Burge C. B., Alternative isoform regulation in human tissue transcriptomes. Nature 2008 456 7221 470 476 2-s2.0-56549101959 10.1038/nature07509 (Pubitemid 352759009)
4. Blencowe B. J., Alternative splicing: new insights from global analyses. Cell 2006 126 1 37 47 2-s2.0-33745899048 10.1016/j.cell.2006.06.023 (Pubitemid 44040990)
5. Castle J. C., Zhang C., Shah J. K., Kulkarni A. V., Kalsotra A., Cooper T. A., Johnson J. M., Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nature Genetics 2008 40 12 1416 1425 2-s2.0-56749164864 10.1038/ng.264
6. Clark T. A., Schweitzer A. C., Chen T. X., Staples M. K., Lu G., Wang H., Williams A., Blume J. E., Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biology 2007 8 4 R64 2-s2.0-34547632484 10.1186/gb-2007-8-4-r64 (Pubitemid 351859198)
7. de la Grange P., Gratadou L., Delord M., Dutertre M., Auboeuf D., Splicing factor and exon profiling across human tissues. Nucleic Acids Research 2010 38 9 2825 2838 2-s2.0-77953249890 10.1093/nar/gkq008 gkq008
8. Kwan T., Benovoy D., Dias C., Gurd S., Provencher C., Beaulieu P., Hudson T. J., Sladek R., Majewski J., Genome-wide analysis of transcript isoform variation in humans. Nature Genetics 2008 40 2 225 231 2-s2.0-38649090044 10.1038/ng.2007.57 (Pubitemid 351171391)
9. Tang F., Barbacioru C., Wang Y., Nordman E., Lee C., Xu N., Wang X., Bodeau J., Tuch B. B., Siddiqui A., Lao K., Surani M. A., mRNA-Seq whole-transcriptome analysis of a single cell. Nature Methods 2009 6 5 377 382 2-s2.0-67349146589 10.1038/nmeth.1315
10. Barash Y., Calarco J. A., Gao W., Pan Q., Wang X., Shai O., Blencowe B. J., Frey B. J., Deciphering the splicing code. Nature 2010 465 7294 53 59 2-s2.0-77952029221 10.1038/nature09000
11. Bland C. S., Wang E. T., Vu A., David M. P., Castle J. C., Johnson J. M., Burge C. B., Cooper T. A., Global regulation of alternative splicing during myogenic differentiation. Nucleic Acids Research 2010 38 21 7651 7664 2-s2.0-78449289265 10.1093/nar/gkq614
12. Johnson M. B., Kawasawa Y. I., Mason C. E., Krsnik Ž., Coppola G., Bogdanović D., Geschwind D. H., Mane S. M., State M. W., Šestan N., Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 2009 62 4 494 509 2-s2.0-65649112466 10.1016/j.neuron.2009.03.027
13. Trapnell C., Williams B. A., Pertea G., Mortazavi A., Kwan G., Van Baren M. J., Salzberg S. L., Wold B. J., Pachter L., Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature Biotechnology 2010 28 5 511 515 2-s2.0-77952123055 10.1038/nbt.1621
14. Hanahan D., dh@epfl.ch Weinberg R. A., weinberg@wi.mit.edu Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 10.1016/j.cell.2011.02.013
15. Kang Y., Massagué J., Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004 118 3 277 279 2-s2.0-4043052971 10.1016/j.cell.2004.07.011 (Pubitemid 39061108)
16. David C. J., Manley J. L., Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes and Development 2010 24 21 2343 2364 2-s2.0-78049416081 10.1101/gad.1973010
17. Dutertre M., Vagner S., Auboeuf D., Alternative splicing and breast cancer. RNA Biology 2010 7 4 403 411 2-s2.0-77957307409 10.4161/rna.7.4.12152
18. Fackenthal J. D., Godley L. A., Aberrant RNA splicing and its functional consequences in cancer cells. Disease Models and Mechanisms 2008 1 1 37 42 2-s2.0-64249084287 10.1242/dmm.000331
19. Grosso A. R., Martins S., Carmo-Fonseca M., The emerging role of splicing factors in cancer. EMBO Reports 2008 9 11 1087 1093 2-s2.0-55549143293 10.1038/embor.2008.189
20. Kim M. Y., Hur J., Jeong S., Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Reports 2009 42 3 125 130 2-s2.0-67449084504
21. Pettigrew C. A., Brown M. A., Pre-mRNA splicing aberrations and cancer. Frontiers in Bioscience 2008 13 3 1090 1105 2-s2.0-38449111154 10.2741/2747 (Pubitemid 351594751)
22. Skotheim R. I., Nees M., Alternative splicing in cancer: noise, functional, or systematic? International Journal of Biochemistry and Cell Biology 2007 39 78 1432 1449 2-s2.0-34447106755 10.1016/j.biocel.2007.02.016 (Pubitemid 47031033)
23. Srebrow A., Kornblihtt A. R., The connection between splicing and cancer. Journal of Cell Science 2006 119, part 13 2635 2641 2-s2.0-33746927884 10.1242/jcs.03053 (Pubitemid 44184000)
24. Venables J. P., Unbalanced alternative splicing and its significance in cancer. BioEssays 2006 28 4 378 386 2-s2.0-33645833000 10.1002/bies.20390
25. Hertel K. J., Combinatorial control of exon recognition. Journal of Biological Chemistry 2008 283 3 1211 1215 2-s2.0-38349127601 10.1074/jbc.R700035200
26. Wahl M. C., Will C. L., Lührmann R., The spliceosome: design principles of a dynamic RNP machine. Cell 2009 136 4 701 718 2-s2.0-60349104299 10.1016/j.cell.2009.02.009
27. Wang Z., Burge C. B., Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 2008 14 5 802 813 2-s2.0-42449098125 10.1261/rna.876308 (Pubitemid 351574901)
28. Körner M., Miller L. J., Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors. American Journal of Pathology 2009 175 2 461 472 2-s2.0-68449085340 10.2353/ajpath.2009.081135
29. Miura K., k-miura@surg1.med.tohoku.ac.jp Fujibuchi W., Sasaki I., Alternative pre-mRNA splicing in digestive tract malignancy. Cancer Science 2011 102 2 309 316 10.1111/j.1349-7006.2010.01797.x
30. Pio R., Montuenga L. M., Alternative splicing in lung cancer. Journal of Thoracic Oncology 2009 4 6 674 678 2-s2.0-67849087126 10.1097/JTO. 0b013e3181a520dc
31. Rajan P., Elliott D. J., Robson C. N., Leung H. Y., Alternative splicing and biological heterogeneity in prostate cancer. Nature Reviews Urology 2009 6 8 454 460 2-s2.0-76649088636 10.1038/nrurol.2009.125
32. Ghigna C., Valacca C., Biamonti G., Alternative splicing and tumor progression. Current Genomics 2008 9 8 556 570 2-s2.0-66049085709 10.2174/138920208786847971
33. Venables J. P., Klinck R., Koh C., Gervais-Bird J., Bramard A., Inkel L., Durand M., Couture S., Froehlich U., Lapointe E., Lucier J. F., Thibault P., Rancourt C., Tremblay K., Prinos P., Chabot B., Elela S. A., Cancer-associated regulation of alternative splicing. Nature Structural and Molecular Biology 2009 16 6 670 676 2-s2.0-67349097457 10.1038/nsmb.1608
34. Lapuk A., Marr H., Jakkula L., Pedro H., Bhattacharya S., Purdom E., Hu Z., Simpson K., Pachter L., Durinck S., Wang N., Parvin B., Fontenay G., Speed T., Garbe J., Stampfer M., Bayandorian H., Dorton S., Clark T. A., Schweitzer A., Wyrobek A., Feiler H., Spellman P., Conboy J., Gray J. W., Exon-level microarray analyses identify alternative splicing programs in breast cancer. Molecular Cancer Research 2010 8 7 961 974 2-s2.0-77955463831 10.1158/1541-7786.MCR-09-0528
35. Dutertre M., Lacroix-Triki M., Driouch K., De La Grange P., Gratadou L., Beck S., Millevoi S., Tazi J., Lidereau R., Vagner S., Auboeuf D., Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis. Cancer Research 2010 70 3 896 905 2-s2.0-76249100558 10.1158/0008-5472.CAN-09-2703
36. Bemmo A., Dias C., Rose A. A. N., Russo C., Siegel P., Majewski J., Exon-Level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities. PLoS ONE 2010 5 8 2-s2.0-77957772409 10.1371/journal.pone.0011981 e11981
37. André F., Michiels S., Dessen P., Scott V., Suciu V., Uzan C., Lazar V., Lacroix L., Vassal G., Spielmann M., Vielh P., Delaloge S., Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. The Lancet Oncology 2009 10 4 381 390 2-s2.0-63149156942 10.1016/S1470-2045(09)70024-5
38. Langer W., Sohler F., Leder G., Beckmann G., Seidel H., Gröne J., Hummel M., Sommer A., Exon Array Analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer. BMC Genomics 2010 11 1 676 2-s2.0-78649491922 10.1186/1471-2164-11-676
39. Xi L., Feber A., Gupta V., Wu M., Bergemann A. D., Landreneau R. J., Litle V. R., Pennathur A., Luketich J. D., Godfrey T. E., Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Research 2008 36 20 6535 6547 2-s2.0-56649083778 10.1093/nar/gkn697
40. Pio R., Blanco D., Pajares M. J., Aibar E., Durany O., Ezponda T., Agorreta J., Gomez-Roman J., Anton M. A., Rubio A., Lozano M. D., López-Picazo J. M., Subirada F., Maes T., Montuenga L. M., Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer. BMC Genomics 2010 11 1 352 2-s2.0-77953005066 10.1186/1471-2164-11-352
41. Misquitta-Ali C. M., Cheng E., O'Hanlon D., Liu N., McGlade C. J., Tsao M. S., Blencowe B. J., b.blencowe@utoronto.ca Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer. Molecular and Cellular Biology 2011 31 1 138 150 10.1128/MCB.00709-10
42. Gardina P. J., Clark T. A., Shimada B., Staples M. K., Yang Q., Veitch J., Schweitzer A., Awad T., Sugnet C., Dee S., Davies C., Williams A., Turpaz Y., Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 2006 7 325 2-s2.0-33846467191 10.1186/1471-2164-7-325 (Pubitemid 46165475)
43. Thorsen K., Sorensen K. D., Brems-Eskildsen A., Modin C., Gaustadnes M., Hein A. M. K., Kruhoffert M., Laurberg S., Borre M., Wang K., Brunak S., Krainer A. R., Torring N., Dyrskjott L., Andersen C. L., Orntoft T. F., Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Molecular and Cellular Proteomics 2008 7 7 1214 1224 2-s2.0-47849097478 10.1074/mcp.M700590-MCP200 (Pubitemid 352038268)
44. Mojica W., Hawthorn L., Normal colon epithelium: a dataset for the analysis of gene expression and alternative splicing events in colon disease. BMC Genomics 2010 11 1 5 2-s2.0-76949087472 10.1186/1471-2164-11-5
45. Sveen A., anita.sveen@rr-research.no Ågesen T. H., trude.holmeide.aagesen@rr-research.no Nesbakken A., arild.nesbakken@aker- sykehus.no Rognum T. O., t.o.rognum@medisin.uio.no Lothe R. A., ragnhild.a.lothe@rr-research.no Skotheim R. I., rolf.i.skotheim@rr-research.no Transcriptome instability in colorectal cancer identified by exon microarray analyses: associations with splicing factor expression levels and patient survival. Genome Medicine 2011 3 5 32 10.1186/gm248
46. Menghi F., Jacques T. S., Barenco M., Schwalbe E. C., Clifford S. C., Hubank M., Ham J., J.Ham@ich.ucl.ac.uk Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development. Cancer Research 2011 71 6 2045 2055 10.1158/0008-5472.CAN-10-2519
47. Guo X., guo424@gmail.com Chen Q. R., chenqi@mail.nih.gov Song Y. K., songyo@mail.nih.gov Wei J. S., weij@mail.nih.gov Khan J., khanjav@mail.nih.gov Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status. BMC Medical Genomics 2011 4 35 10.1186/1755-8794-4-35
48. Cheung H. C., Baggerly K. A., Tsavachidis S., Bachinski L. L., Neubauer V. L., Nixon T. J., Aldape K. D., Cote G. J., Krahe R., Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays. BMC Genomics 2008 9 216 2-s2.0-44649126097 10.1186/1471-2164-9-216 (Pubitemid 351785140)
49. French P. J., Peeters J., Horsman S., Duijm E., Siccama I., Van Den Bent M. J., Luider T. M., Kros J. M., Van Der Spek P., Sillevis Smitt P. A., Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. Cancer Research 2007 67 12 5635 5642 2-s2.0-34250795169 10.1158/0008-5472.CAN-06-2869 (Pubitemid 46984994)
50. Zhang C., Zhang Z., Castle J., Sun S., Johnson J., Krainer A. R., Zhang M. Q., Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes and Development 2008 22 18 2550 2563 2-s2.0-51949111100 10.1101/gad.1703108
51. Yeo G. W., Coufal N. G., Liang T. Y., Peng G. E., Fu X. D., Gage F. H., An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nature Structural and Molecular Biology 2009 16 2 130 137 2-s2.0-59649107040 10.1038/nsmb.1545
52. Ule J., Ule A., Spencer J., Williams A., Hu J. S., Cline M., Wang H., Clark T., Fraser C., Ruggiu M., Zeeberg B. R., Kane D., Weinstein J. N., Blume J., Darnell R. B., Nova regulates brain-specific splicing to shape the synapse. Nature Genetics 2005 37 8 844 852 2-s2.0-23044431574 10.1038/ng1610 (Pubitemid 41077110)
53. Zhang C., Frias M. A., Mele A., Ruggiu M., Eom T., Marney C. B., Wang H., Licatalosi D. D., Fak J. J., Darnell R. B., Integrative modeling defines the nova splicing-regulatory network and its combinatorial controls. Science 2010 329 5990 439 443 2-s2.0-77954838957 10.1126/science.1191150
54. Warzecha C. C., Jiang P., Amirikian K., Dittmar K. A., Lu H., Shen S., Guo W., Xing Y., Carstens R. P., An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO Journal 2010 29 19 3286 3300 2-s2.0-77957767273 10.1038/emboj.2010.195
55. Warzecha C. C., Sato T. K., Nabet B., Hogenesch J. B., Carstens R. P., ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Molecular Cell 2009 33 5 591 601 2-s2.0-61649087689 10.1016/j.molcel.2009.01.025
56. Warzecha C. C., Shen S., Xing Y., Carstens R. P., The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events. RNA Biology 2009 6 5 546 562 2-s2.0-77950552549
57. Hanahan D., Weinberg R. A., The hallmarks of cancer. Cell 2000 100 1 57 70 2-s2.0-0034614637 (Pubitemid 30046295)
58. Schwerk C., Schulze-Osthoff K., Regulation of apoptosis by alternative pre-mRNA splicing. Molecular Cell 2005 19 1 1 13 2-s2.0-21244439380 10.1016/j.molcel.2005.05.026 (Pubitemid 40884653)
59. Moore M. J., Wang Q., Kennedy C. J., Silver P. A., An alternative splicing network links cell-cycle control to apoptosis. Cell 2010 142 4 625 636 2-s2.0-77955662560 10.1016/j.cell.2010.07.019
60. Boger-Nadjar E., Vaisman N., Ben-Yehuda S., Kassir Y., Kupiec M., Efficient initiation of S-phase in yeast requires Cdc40p, a protein involved in pre-mRNA splicing. Molecular and General Genetics 1998 260 2-3 232 241 2-s2.0-0031736258 10.1007/s004380050891 (Pubitemid 28548323)
61. Li X., Wang J., Manley J. L., Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation. Genes and Development 2005 19 22 2705 2714 2-s2.0-27744441269 10.1101/gad.1359305 (Pubitemid 41627937)
62. Zhang N., Kaur R., Akhter S., Legerski R. J., Cdc5L interacts with ATR and is required for the S-phase cell-cycle checkpoint. EMBO Reports 2009 10 9 1029 1035 2-s2.0-69949120911 10.1038/embor.2009.122
63. Merdzhanova G., Edmond V., De Seranno S., Van den Broeck A., Corcos L., Brambilla C., Brambilla E., Gazzeri S., Eymin B., E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35. Cell Death and Differentiation 2008 15 12 1815 1823 2-s2.0-56349095800 10.1038/cdd.2008.135
64. Merdzhanova G., Gout S., Keramidas M., Edmond V., Coll J. L., Brambilla C., Brambilla E., Gazzeri S., Eymin B., The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo. Oncogene 2010 29 39 5392 5403 2-s2.0-77957596291 10.1038/onc.2010.281
65. Edmond V., Moysan E., Khochbin S., Matthias P., Brambilla C., Brambilla E., Gazzeri S., Eymin B., Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin. EMBO Journal 2011 30 3 510 523 10.1038/emboj.2010.333
66. Karni R., de Stanchina E., Lowe S. W., Sinha R., Mu D., Krainer A. R., The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nature Structural and Molecular Biology 2007 14 3 185 193 2-s2.0-33847630730 10.1038/nsmb1209 (Pubitemid 46355578)
67. Piekielko-Witkowska A., Wiszomirska H., Wojcicka A., Poplawski P., Boguslawska J., Tanski Z., Nauman A., Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors. PLoS ONE 2010 5 10 2-s2.0-78149455880 10.1371/journal.pone.0013690 e13690
68. Ghigna C., Giordano S., Shen H., Benvenuto F., Castiglioni F., Comoglio P. M., Green M. R., Riva S., Biamonti G., Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Molecular Cell 2005 20 6 881 890 2-s2.0-29144447982 10.1016/j.molcel.2005.10.026 (Pubitemid 41814877)
69. Babic I., Jakymiw A., Fujita D. J., The RNA binding protein Sam68 is acetylated in tumor cell lines, and its acetylation correlates with enhanced RNA binding activity. Oncogene 2004 23 21 3781 3789 2-s2.0-2342580076 10.1038/sj.onc.1207484 (Pubitemid 38725691)
70. Busà R., Paronetto M. P., Farini D., Pierantozzi E., Botti F., Angelini D. F., Attisani F., Vespasiani G., Sette C., The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene 2007 26 30 4372 4382 2-s2.0-34347348168 10.1038/sj.onc.1210224 (Pubitemid 47014462)
71. Lukong K. E., Larocque D., Tyner A. L., Richard S., Tyrosine phosphorylation of Sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. Journal of Biological Chemistry 2005 280 46 38639 38647 2-s2.0-33644663231 10.1074/jbc.M505802200 (Pubitemid 43853766)
72. Paronetto M. P., Farini D., Sammarco I., Maturo G., Vespasiani G., Geremia R., Rossi P., Sette C., Expression of a truncated form of the c-kit tyrosine kinase receptor and activation of Src kinase in human prostatic cancer. American Journal of Pathology 2004 164 4 1243 1251 2-s2.0-1642292426 (Pubitemid 38387791)
73. Rajan P., Gaughan L., Dalgliesh C., El-Sherif A., Robson C. N., Leung H. Y., Elliott D. J., Regulation of gene expression by the RNA-binding protein Sam68 in cancer. Biochemical Society Transactions 2008 36 3 505 507 2-s2.0-45249109123 10.1042/BST0360505 (Pubitemid 351839363)
74. Liu K., Li L., Nisson P. E., Gruber C., Jessee J., Cohen S. N., Neoplastic transformation and tumorigenesis associated with Sam68 protein deficiency in cultured murine fibroblasts. Journal of Biological Chemistry 2000 275 51 40195 40201 2-s2.0-0034704172 10.1074/jbc.M006194200 (Pubitemid 32064649)
75. Taylor S. J., Resnick R. J., Shalloway D., Sam68 exerts separable effects on cell cycle progression and apoptosis. BMC Cell Biology 2004 5 5 2-s2.0-2342547025 10.1186/1471-2121-5-5 (Pubitemid 38597779)
76. Bielli P., Busa R., Paronetto M. P., Sette C., The RNA-binding protein Sam68 is a multifunctional player in human cancer. Endocrine-Related Cancer 2011 18 4 R91 R102
77. Matter N., Herrlich P., König H., Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 2002 420 6916 691 695 2-s2.0-0037069651 10.1038/nature01153 (Pubitemid 36764503)
78. Paronetto M. P., Achsel T., Massiello A., Chalfant C. E., Sette C., The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. Journal of Cell Biology 2007 176 7 929 939 2-s2.0-33947712084 10.1083/jcb.200701005 (Pubitemid 46506967)
79. Valacca C., Bonomi S., Buratti E., Pedrotti S., Baralle F. E., Sette C., Ghigna C., Biamonti G., Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. Journal of Cell Biology 2010 191 1 87 99 2-s2.0-77957726684 10.1083/jcb. 201001073
80. Paronetto M. P., Cappellari M., Busà R., Pedrotti S., Vitali R., Comstock C., Hyslop T., Knudsen K. E., Sette C., Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68. Cancer Research 2010 70 1 229 239 2-s2.0-75149187424 10.1158/0008-5472.CAN-09-2788
81. Llorian M., Schwartz S., Clark T. A., Hollander D., Tan L. Y., Spellman R., Gordon A., Schweitzer A. C., De La Grange P., Ast G., Smith C. W. J., Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nature Structural and Molecular Biology 2010 17 9 1114 1123 2-s2.0-77956342570 10.1038/nsmb.1881
82. Xue Y., Zhou Y., Wu T., Zhu T., Ji X., Kwon Y. S., Zhang C., Yeo G., Black D. L., Sun H., Fu X. D., Zhang Y., Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Molecular Cell 2009 36 6 996 1006 2-s2.0-72149117411 10.1016/j.molcel.2009.12.003
83. Cheung H. C., Hai T., Zhu W., Baggerly K. A., Tsavachidis S., Krahe R., Cote G. J., Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines. Brain 2009 132 8 2277 2288 2-s2.0-67749110060 10.1093/brain/awp153
84. David C. J., Chen M., Assanah M., Canoll P., Manley J. L., HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010 463 7279 364 368 2-s2.0-75149150660 10.1038/nature08697
85. He X., Pool M., Darcy K. M., Lim S. B., Auersperg N., Coon J. S., Beck W. T., Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene 2007 26 34 4961 4968 2-s2.0-34547489950 10.1038/sj.onc.1210307 (Pubitemid 47172653)
86. Jin W., Bruno I. G., Xie T. X., Sanger L. J., Cote G. J., Polypyrimidine tract-binding protein down-regulates fibroblast growth factor receptor 1 α -exon inclusion. Cancer Research 2003 63 19 6154 6157 2-s2.0-0141885135 (Pubitemid 37255155)
87. Boutz P. L., Stoilov P., Li Q., Lin C. H., Chawla G., Ostrow K., Shiue L., Ares M., Black D. L., A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes and Development 2007 21 13 1636 1652 2-s2.0-34347384211 10.1101/gad.1558107 (Pubitemid 47026368)
88. Clower C. V., Chatterjee D., Wang Z., Cantley L. C., Heidena M. G. V., Krainer A. R., The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proceedings of the National Academy of Sciences of the United States of America 2010 107 5 1894 1899 2-s2.0-76649102764 10.1073/pnas.0914845107
89. Hatakeyama K., k.hatakeyama@scchr.jp Ohshima K., Fukuda Y., Ogura S. I., Terashima M., Yamaguchi K., Mochizuki T., Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteome. Proteomics 2011 11 11 2275 2282 10.1002/pmic.201100016
90. Bates D. O., Cui T. G., Doughty J. M., Winkler M., Sugiono M., Shields J. D., Peat D., Gillatt D., Harper S. J., VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Research 2002 62 14 4123 4131 2-s2.0-0037098860 (Pubitemid 34791084)
91. Nowak D. G., Woolard J., Amin E. M., Konopatskaya O., Saleem M. A., Churchill A. J., Ladomery M. R., Harper S. J., Bates D. O., Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. Journal of Cell Science 2008 121 20 3487 3495 2-s2.0-56349136033 10.1242/jcs.016410
92. Christofk H. R., Vander Heiden M. G., Harris M. H., Ramanathan A., Gerszten R. E., Wei R., Fleming M. D., Schreiber S. L., Cantley L. C., The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008 452 7184 230 233 2-s2.0-40749163248 10.1038/nature06734 (Pubitemid 351380249)
93. Mazurek S., Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. International Journal of Biochemistry and Cell Biology 2011 43 7 969 980 10.1016/j.biocel.2010.02.005
94. Medina M. W., mwmedina@chori.org Gao F., Naidoo D., Rudel L. L., Temel R. E., McDaniel A. L., Marshall S. M., Krauss R. M., rkrauss@chori.org Coordinately regulated alternative splicing of genes involved in cholesterol biosynthesis and uptake. PLoS ONE 2011 6 4, article e19420 10.1371/journal.pone. 0019420
95. Prinos P., Garneau D., Lucier J. F., Gendron D., Couture S., Boivin M., Brosseau J. P., Lapointe E., Thibault P., Durand M., Tremblay K., Gervais-Bird J., Nwilati H., Klinck R., Chabot B., Perreault J. P., Wellinger R. J., Elela S. A., sherif.abou.elela@usherbrooke.ca Alternative splicing of SYK regulates mitosis and cell survival. Nature Structural and Molecular Biology 2011 18 6 673 679 10.1038/nsmb.2040
96. Pajares M. J., Ezponda T., Catena R., Calvo A., Pio R., Montuenga L. M., Alternative splicing: an emerging topic in molecular and clinical oncology. The Lancet Oncology 2007 8 4 349 357 2-s2.0-33947541694 10.1016/S1470-2045(07)70104- 3 (Pubitemid 46464532)
97. Ward A. J., Cooper T. A., The pathobiology of splicing. Journal of Pathology 2010 220 2 152 163 2-s2.0-73949128867 10.1002/path.2649
98. Ghigna C., De Toledo M., Bonomi S., Valacca C., Gallo S., Apicella M., Eperon I., Tazi J., Biamonti G., Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives. RNA Biology 2010 7 4 495 503 2-s2.0-77957302252 10.4161/rna.7.4.12744
99. Tazi J.Bakkour N. Stamm S 2-s2.0-57849150788 10.1016/j.bbadis.2008.09.017